Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-01-11
2008-09-16
Peselev, Elli (Department: 1623)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C562S899000
Reexamination Certificate
active
07425635
ABSTRACT:
Disclosed are compounds having the formulawherein R1is hydrogen, an alkyl group, an aryl group, a cycloalkyl group, an alkenyl group, an alkynyl group, an aralkyl group, or ═O,R2is an alkyl group, an aryl group, a cycloalkyl group, an alkenyl group, an alkynyl group, or an aralkyl group,or the pharmaceutically acceptable salt or ester thereof. Also disclosed are methods of using the compounds.
REFERENCES:
patent: 3710795 (1973-01-01), Higuchi et al.
patent: 4011221 (1977-03-01), Sakakibara et al.
patent: 4617189 (1986-10-01), Stockel et al.
patent: 4868114 (1989-09-01), Nagasawa et al.
patent: 5578470 (1996-11-01), Kerkenaar et al.
patent: 5667791 (1997-09-01), Hersh et al.
patent: 6340746 (2002-01-01), Roberts et al.
patent: 6841536 (2005-01-01), Roberts et al.
patent: 0 277 688 (1993-10-01), None
patent: WO 91/02741 (1991-07-01), None
Antonucci et al, Bulletin of Molecular Biology and Medicine, vol. 2(2), pp. 80-84, Jun. 1977, “Inhibition of Protein Synthesis in Rabbit Reticulocytes”.
Baran and Drabarek “Studies on Synthesis of S-Glycosidic Bond Between Cysteine and Glucose or Galactose.”Polish J. Chem.52:941-946 (1978).
Baruchel et al. “In vivo Selective Modulation of Tissue Glutathione in a Rat Mammary Carcinoma Model.”Biochem. Pharmacol50(9):1505-1508 (1995).
Bezlepkin et al. “The Prolongation of Survival in Mice by Dietary Antioxidants Depends on their Age by the Start of Feeding this Diet.”Mechanisms of Ageing and Development92:227-234 (1996).
Blot et al. “Nutrition Intervention Trials in Linxian, China: Supplementation with Specific Vitamin/Mineral Combinations, Cancer Incidence, and Disease-specific Mortality in the General Population.”J Natl Cancer Inst.85(18):1483-1492 (Sep. 15, 1993).
Bohm et al. “A Feasibility Study of Cisplatin Administration with Low-Volume Hydration and Glutathione Protecting in the Treatment of Ovarian Carcinoma.”Anticancer Res11:1613-1616 (1991).
Boucher et al. “Oral Selenium Supplementation in Rats Reduces Cardiac Toxicity of Adriamycin During Ischemia and Reperfusion.”Nutrition. 11(5 Suppl):708-11 (Sep.-Oct. 1995).
Brock et al. “Serum Selenium Level in Relation to In situ Cervical Cancer in Australia.”J Natl Cancer Inst.83(4):292-3 (Feb. 20, 1991).
Carroll et al. “Efficacy of Radioprotective Agents in Preventing Small and Large Bowel Radiation Injury.”Dis Colon Rectum.38(7):716-722 (Jul. 1995).
Clark et al. “Selenium in Forage Crops and Cancer Mortality in U.S. Counties.”Arch Environ Health.46(1):37-42 (Jan.-Feb. 1991).
Clark et al. “Decreased Incidence of Prostate Cancer with Selenium Supplementation: Results of a Double-blind Cancer Prevention Trial.”Br J Urol.81(5):730-4 (May 1998).
Clark et al. “Effects of Selenium Supplementation for Cancer Prevention in Patients with Carcinoma of the Skin.”JAMA276(24):1957-1963 (1996).
Crary et al. “Potential Clinical Applications for High-Dose Nutritional Antioxidants.”Medical Hypotheses13:77-98 (1984).
Diamond et al. “The Inhibition of Radiation-induced Mutagenesis by the Combined Effects of Selenium and the Aminothiol WR-1065.”Mutat Res.356(2):147-54 (Sep. 23, 1996).
Dorr, Robert“Chemoprotectants for Cancer Chemotherapy.”Seminars in Oncology18(1): Suppl 2:48-58 (1991).
Draguet and Renson “Synthese de la Selenazolidine, de N-Alcoylselenazolidines et de Leurs Derives de Substitution en 2Bull.” Soc. Chim. Belges81:279-287 (1972).
El-Bayoumy et al. “Chemoprevention of Cancer by Organoselenium Compounds.”J. Cell. Biochem.Supplement 22:92-100. (1995).
Goitein et al. “Future Prospects in Planning Radiation Therapy.”Cancer55(9 Suppl):2234-9 (1985).
Hildesheim et al. “Etude de L'inhibitond'une t-ARN N2-guanin methyl transferase de foie de lapin par des analogues de la S-adensoyl homocyseine.”Biochimie1972;54:989-995 (May 1, 1985).
Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes: Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academy Press, Washington, DC, 2000.
Ip et al. “In vitro and In vivo Studies of Methylseleninic Acid: Evidence that a Monomethylated Selenium Metabolite is Critical for Cancer Chemoprevention.”Cancer Res.60(11):2882-6 (Jun. 1, 2000).
Johansen et al. “Relationship Between the in vitro Radiosensitivity of Skin Fibroblasts and the Expression of Subcutaneous Fibrosis, Telangiectasia, and Skin Erythema After Radiotherapy,”Radiother Oncol.40(2):101-9 (Aug. 1996).
Käsbeck and Kessler “Synthesis of S-α-D-Glucosylated L-Cysteine—A Novel S-Glycosyl Amino Acid.”Liebigs Ann/Recueil165-167 (1997).
Knizhnikov et al. “The Effect of Dietary Levels of Selenium on Radiation Resistance . . . ”Nutrition Research16 (3): 505-516 (1996).
Konstantinov et al. “Antitumor, Nephrotoxic and Clastongenic Effect of cis-DDP with DDTC or NAC.”Neoplasma41(5):253-258 (1994).
Kumar et al. “Radioprotection by Antioxidant Enzymes and Enzyme Mimetics”Pharmac. Ther.39:309-309 (1998).
Lautermann et al. “Glutathione Protection against Gentamicin Ototoxicity Depends on Nutritional Status.”Hearing Research86:15-24 (1995).
Leyck and Parnham “Acute Antiinflammatory and Gastric Effects of the Seleno-organic Compound Ebselen.”Agents Actions.Jun.;30(3-4):426-31 (1990).
Li et al. “Charateritics of Selenazolidine Prodrugs of Selenocysteine: Toxicity, Selenium Levels, and Gluthaion Peroxidase Induction in A/J Mice.”Life Sciences75:447-459 (2004).
Li et al. “Chemoprotective Activity of Selenocystein Prodrugs Against the Tobacco Derived Nitrosamine NNK in the A/J Mouse Lung.” Univ. Wisconsin.
Micke O, et al. “Selenium in the Treatment of Radiation-associated Secondary Lymphedema.”Int J Radiat Oncol Biol Phys.56(1):40-9 (May 1, 2003).
Monsigny et al. “Synthèse d'un nouveau type de glycoconjuguèLe thio-β-D-glucopyranoside de la L-cystèine.”Carbohydrate Res.59:589-593 (1997).
Nagasawa et al. “Prodrugs of L-Cysteine as Liver-Protective Agents, 2(RS)-Methylthiazolidine4R-Carboxylic Acid, a Latent Cysteine.”J. Med. Chem.25(5):489-491 (1982).
Niemierko and Goitein “Modeling of Normal Tissue Response to Radiation: The Critical Volume Model.”Int J Radiat Oncol Biol Phys.25(1):135-45 (Jan. 1993).
Reddy et al. “Evaluation of Organoselenium Compounds for Potential Chemopreventive Properties in Colon Cancer.”Anticancer Res.16(3A):1123-7 (May-Jun. 1996).
Remington's Pharmaceutical Sciences, latest edition, by E.W. Martin Mack Pub. Co., Easton, PA.
Roberts and Francetic “Chemoprotection Against Cyclophosphamide-induced Urotoxicity: Ribose-Cysteine.”Anticancer Res.14:383-388 (1994).
Roberts and Francetic “Mechanisms of Chemoprotection by Ribcys, a Thiazolidine Prodrug of L-Cysteine.”Med. Chem. Res.1:213-219 (1991).
Roberts and Francetic. “Time Course for the Elevation of Gluthahione in Numerous Organs of L1210-Bearing CDF1 Mice Given the L-Cytseine Prodrug, RibCys.”Toxicology Letters59:245-251 (1991).
Roberts et al. “Chemoprotection Against Cyclophosphamide-induced Urotoxicity: Comparison of Nine Thoil Protective Agents.”Anticancer Res.14:389-396 (1994).
Roberts et al. “Differential Chemoprotection Against Acetaminophen-Induced Hepatotoxicity by Latentiated L-Cysteines.”Chem. Res. Toxicol.(Sep. 1998).
Roberts et al. “L-cysteine Prodrug Protects against Cyclophosphamide Urotoxicity Without Comprising Therapeutic Activity.”Cancer Chemther. Pharmacol.28:166-170 (1991).
Roberts et al. “Prodrugs of L-Cysteine as Protective Agents Against Acetaminophen-induced Hepatotoxicity. 2—(Polyhydroxyalkyl)- and 2-(polyacetoxyalkyl)thiazolidine-4(R) -carboxylic acids.”J. of Med. Chem.30:1891-1896 (1987).
Roberts et al.
Aboul-Fadl Trek
Franklin Michael R.
Roberts Jeanette
Ballard Spahr Andrews & Ingersoll LLP
Peselev Elli
University of Utah Research Foundation
LandOfFree
Prodrugs and conjugates of thiol- and selenol-containing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prodrugs and conjugates of thiol- and selenol-containing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prodrugs and conjugates of thiol- and selenol-containing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3982140